FIELD: medicine.
SUBSTANCE: invention concerns pharmaceutical compositions for preventive maintenance of development and treatment of an initial stage of an age cataract. The pharmaceutical composition (versions) contains the active beginning an admixture of two short-chain peptides and the suitable pharmaceutical carrier. In the first version - admixture of D-pantethine and N-acetylcarnosin at the following concentration of components: D-pantethine-not less than 0.001%, N-acetylcarnosin - not less than 0.001%, a normal saline solution - to 100%. In the second version - admixture D-pantethine and L-carnosin at the following concentration of components: D-pantethine - not less than 0.001%, L-carnosin - not less than 0.001%, a normal saline solution - to 100%.
EFFECT: high efficiency of the offered pharmaceutical composition is caused by that the components entering into composition; selectively protect different fibers of the lens of an eye.
2 cl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS | 2009 |
|
RU2404768C1 |
THERAPY OF EARLY CATARACT | 2008 |
|
RU2367387C1 |
METHOD OF AGE-SPECIFIC CATARACT MODELLING | 2007 |
|
RU2336574C1 |
EYE DROPS FOR CATARACT TREATMENT | 1993 |
|
RU2071316C1 |
BIOREGULATORY COMPLEX POSSESSING TISSUE-SPECIFIC REGENERATIVE ACTION, METHOD FOR PREPARING IT AND METHOD OF TREATING CATARACT USING IT | 2012 |
|
RU2513994C2 |
DRUG PREPARATION FOR TREATING CATARACT AND METHOD FOR PREPARING IT (VERSIONS) | 2012 |
|
RU2536958C2 |
PEPTIDES FOR SKIN REJUVENATION AND METHODS OF THEIR USAGE | 2014 |
|
RU2666533C2 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
PSEUDODIPEPTIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT | 1994 |
|
RU2166510C2 |
Authors
Dates
2009-04-20—Published
2007-12-03—Filed